SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-21-004529
Filing Date
2021-04-15
Accepted
2021-04-15 17:00:32
Documents
152
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT admp-10k_123120.htm   iXBRL 10-K 2727856
2 DESCRIPTION OF CAPITAL STOCK ex4-6.htm EX-4.6 48710
3 FIRST AMENDMENT TO LEASE ex10-20.htm EX-10.20 6071
4 LEASE AGREEMENT ex10-72.htm EX-10.72 14712
5 PROMISSORY NOTE DATED MARCH 15, 2021 ex10-73.htm EX-10.73 74274
6 SUBSIDIARIES ex21-1.htm EX-21.1 5153
7 CONSENT OF BDO USA, LLP ex23-1.htm EX-23.1 6576
8 CONSENT OF MAYER HOFFMAN MCCANN P.C. ex23-2.htm EX-23.2 5748
9 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 14875
10 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 14899
11 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 7070
12 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 7119
18 GRAPHIC image_001.gif GRAPHIC 254766
19 GRAPHIC image_002.gif GRAPHIC 361796
20 GRAPHIC image_003.gif GRAPHIC 190202
21 GRAPHIC image_004.gif GRAPHIC 50372
22 GRAPHIC image_005.gif GRAPHIC 213443
23 GRAPHIC image_006.gif GRAPHIC 43590
24 GRAPHIC image_007.gif GRAPHIC 225183
25 GRAPHIC ex10-72_img001.gif GRAPHIC 138956
26 GRAPHIC ex10-72_img002.gif GRAPHIC 177112
27 GRAPHIC ex10-72_img003.gif GRAPHIC 179183
28 GRAPHIC ex10-72_img004.gif GRAPHIC 174092
29 GRAPHIC ex10-72_img005.gif GRAPHIC 176065
30 GRAPHIC ex10-72_img006.gif GRAPHIC 174919
31 GRAPHIC ex10-72_img007.gif GRAPHIC 183834
32 GRAPHIC ex10-72_img008.gif GRAPHIC 166344
33 GRAPHIC ex10-72_img009.gif GRAPHIC 149917
34 GRAPHIC ex10-72_img010.gif GRAPHIC 163504
35 GRAPHIC ex10-72_img011.gif GRAPHIC 170130
36 GRAPHIC ex10-72_img012.gif GRAPHIC 118485
37 GRAPHIC ex10-72_img013.gif GRAPHIC 151333
38 GRAPHIC ex10-72_img014.jpg GRAPHIC 312244
39 GRAPHIC ex10-72_img015.gif GRAPHIC 7927
40 GRAPHIC ex10-72_img016.gif GRAPHIC 130141
41 GRAPHIC ex10-72_img017.gif GRAPHIC 160211
42 GRAPHIC ex10-72_img018.gif GRAPHIC 22905
43 GRAPHIC ex10-72_img019.gif GRAPHIC 85602
44 GRAPHIC ex10-74_img001.gif GRAPHIC 90949
45 GRAPHIC ex10-73_img001.gif GRAPHIC 169168
46 GRAPHIC ex10-73_img002.gif GRAPHIC 28658
47 GRAPHIC ex10-1_img001.jpg GRAPHIC 3234
  Complete submission text file 0001387131-21-004529.txt   19137061

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE admp-20201231.xsd EX-101.SCH 77851
14 XBRL CALCULATION FILE admp-20201231_cal.xml EX-101.CAL 113684
15 XBRL DEFINITION FILE admp-20201231_def.xml EX-101.DEF 375305
16 XBRL LABEL FILE admp-20201231_lab.xml EX-101.LAB 585628
17 XBRL PRESENTATION FILE admp-20201231_pre.xml EX-101.PRE 541478
48 EXTRACTED XBRL INSTANCE DOCUMENT admp-10k_123120_htm.xml XML 2540493
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36242 | Film No.: 21829166
SIC: 2834 Pharmaceutical Preparations